Hpv and oropharyngeal cancer


Predictive value of HPV p53 and p16 in the prognosis of oropharyngeal cancer.

hpv and oropharyngeal cancer

Source: ORL. The increasing incidence of oropharyngeal cancers has led the medical scientific world to look for new etiologies, in addition to the traditional ones alcohol and tobacco consumption. Thus, it has been shown that the human papillomavirus HPV brings changes in the human DNA that affect the cell cycle, leading to an aberrant proliferation of tumor cells by altering the production of p53 and p16 proteins.

hpv and oropharyngeal cancer

Materials and method. Results and discussion.

hpv and oropharyngeal cancer

A statistical processing of the obtained data was performed, which allowed the evaluation of the degree of involvement of HPV infection in the prognosis of these cases and in the choice of treatment. The results of the study were consistent with those published in the literature, and the extraction of HPV DNA from the tumor should change the treatment plan for oropharyngeal SCC. The development of new national oncological guidelines related to this pathology would lead to an improvement in the survival rate and the quality of life of patients.

An Interprofessional Approach to HPV and Oropharyngeal Cancer Prevention Education

Copyright of ORL. However, users may print, download, or email articles for individual use. This abstract may be abridged.

  • Vierme rotunde în simptomele plămânilor
  • Hemoparaziți de păsări
  • EBSCOhost | | Laryngeal papillomatosis – clinical and therapeutic considerations.

No warranty is given about the accuracy of the copy. Users hpv and oropharyngeal cancer refer to the original published version of the material for the full abstract.

hpv and oropharyngeal cancer

Important User Information: Remote access to EBSCO's databases is permitted to patrons of subscribing institutions accessing from remote locations for personal, non-commercial use. However, remote access to EBSCO's databases from non-subscribing institutions is not allowed if the purpose of the use is for commercial gain through cost reduction or avoidance for a non-subscribing institution.